Premium
Medtronic Plc (2M6)
TG
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | 9,15k | 0,00 | Derivative Exercise and Retained Stock | - | 33,80k | 37,12% |
| 2026-05-26 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | 94,96k | 0,00 | Derivative Exercise and Retained Stock | - | 231,40k | 69,60% |
| 2026-05-26 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | 18,99k | 0,00 | Derivative Exercise and Retained Stock | - | 32,17k | 144,12% |
| 2026-05-26 | Mr. Brett A. WallExecutive Officer | 26,91k | 0,00 | Derivative Exercise and Retained Stock | - | 48,34k | 125,56% |
| 2026-05-26 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | 15,20k | 0,00 | Derivative Exercise and Retained Stock | - | 17,24k | 744,12% |
| 2026-05-26 | Ms. Denise L. BlomquistVP, Global Controller & CAO | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 6,81k | 33,61% |
| 2026-05-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | -35,00 | 2,80k | Sale to Issuer | 80,00 | 24,55k | -0,14% |
| 2026-04-28 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -318,00 | 26,04k | Sale to Issuer | 81,90 | 5,09k | -5,88% |
| 2026-04-28 | Mr. Kendall J. PowellIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 24,04k | -0,85% |
| 2026-04-28 | Dr. Elizabeth G. NabelIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 17,47k | -1,17% |
| 2026-04-28 | Mr. Kevin E. LoftonIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 8,03k | -2,51% |
| 2026-04-28 | Mr. Gregory Peter LewisIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 3,64k | -5,38% |
| 2026-04-28 | Mr. Randall J. HoganIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 46,89k | -0,44% |
| 2026-04-28 | Mr. Scott C. DonnellyIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 21,57k | -0,95% |
| 2026-04-28 | Ms. Lidia L. FonsecaIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 5,53k | -3,61% |
| 2026-04-28 | Mr. Craig ArnoldLead Independent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 40,07k | -0,51% |
| 2026-03-03 | Mr. Thierry PietonExec. VP & CFO | -2,98k | 287,81k | Sale to Issuer | 96,71 | 6,96k | -29,96% |
| 2026-02-19 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -50,88k | 346,52k | Derivative Exercise and Sale | 80,00 - 97,86 | 1,77k | - |
| 2026-02-19 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -1,65k | 161,18k | Vente | 97,77 - 97,83 | 1,77k | -48,19% |
| 2026-02-20 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -340,00 | 0,00 | Other Disposition | - | 4,31k | -7,31% |
| 2026-01-29 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -148,00 | 14,95k | Sale to Issuer | 101,00 | 4,65k | -3,08% |
| 2025-12-15 | Mr. Brett A. WallExecutive Officer | -439,00 | 43,84k | Sale to Issuer | 99,87 | 20,90k | -2,06% |
| 2025-12-15 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -1,37k | 136,92k | Sale to Issuer | 99,87 | 12,40k | -9,96% |
| 2025-12-15 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | -1,56k | 156,20k | Sale to Issuer | 99,87 | 134,70k | -1,15% |
| 2025-12-05 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -1,70k | 172,51k | Sale to Issuer | 101,36 | 3,18k | -34,86% |
| 2025-11-20 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -170,00 | 0,00 | Other Disposition | - | 4,31k | -3,79% |
| 2025-11-19 | Mr. Gregory L. SmithInitié | -30,00k | 3,06M | Vente | 101,93 - 102,08 | 36,23k | -45,30% |
| 2025-09-03 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -8,61k | 788,05k | Vente | 91,58 - 91,59 | 2,42k | -78,06% |
| 2025-08-22 | Mr. William R. JellisonIndependent Director | 5,00k | 462,75k | Achat | 92,37 - 92,73 | 5,00k | - |
| 2025-08-20 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -1,05k | 98,07k | Sale to Issuer | 93,22 | 13,52k | -7,22% |
| 2025-08-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | 1,23k | 6,55k | Derivative Exercise and Retained Stock | 78,00 | 24,02k | 5,41% |
| 2025-08-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | -1,91k | 102,08k | Derivative Exercise and Sale | 78,00 - 89,34 | 24,02k | - |
| 2025-08-01 | Mr. Brett A. WallExecutive Officer | 3,66k | 0,00 | Derivative Exercise and Retained Stock | - | 21,09k | 20,96% |
| 2025-08-01 | Mr. Brett A. WallExecutive Officer | -11,59k | 1,04M | Derivative Exercise and Sale | 89,34 | 21,09k | - |
| 2025-08-01 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | 21,15k | 218,56k | Derivative Exercise and Retained Stock | 78,00 | 135,43k | 18,51% |
| 2025-08-01 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | -77,18k | 3,95M | Derivative Exercise and Sale | 78,00 - 89,34 | 135,43k | - |
| 2025-08-01 | Mr. Gregory L. SmithInitié | 4,21k | 0,00 | Derivative Exercise and Retained Stock | - | 25,59k | 19,72% |
| 2025-08-01 | Mr. Gregory L. SmithInitié | -7,11k | 635,56k | Derivative Exercise and Sale | 89,34 | 25,59k | - |
| 2025-08-01 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | 1,90k | 20,44k | Derivative Exercise and Retained Stock | 78,00 | 14,57k | 14,98% |
| 2025-08-01 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -7,76k | 470,15k | Derivative Exercise and Sale | 78,00 - 89,34 | 14,57k | - |
| 2025-08-01 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | 2,90k | 0,00 | Derivative Exercise and Retained Stock | - | 11,02k | 35,73% |
| 2025-08-01 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -7,56k | 674,96k | Derivative Exercise and Sale | 89,34 | 11,02k | - |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | 460,00 | 16,69k | Derivative Exercise and Retained Stock | 78,00 | 4,38k | 11,73% |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -58,00 | 5,18k | Derivative Exercise and Sale | 89,34 | 4,38k | - |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -457,00 | 40,83k | Sale to Issuer | 89,34 | 4,38k | -9,45% |
| 2025-07-31 | Mr. Gregory L. SmithInitié | -1,63k | 147,09k | Sale to Issuer | 90,24 | 21,37k | -7,09% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
